STRATUS CS ACUTE CARE MB ISOENZYME OF CREATINE KINASE - Stratus Cs Acute Care Ckmb Testpak.
510(k) K051650
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK051650 | Date8 Sep 2005 | StatusActive |
Recalls
-
- Ongoing Z-1673-2025
Siemens Healthcare Diagnostics Inc., is recalling their Stratus CS Acute Care cTNI TestPak, an IVD test for cardiac troponin I in heparinized plasma by removal. The reason for the recall is an increased occurrence of random non-repeatable false positive cardiac Troponin l(cTnI) results at any point during the TestPaks shelf life when using the Stratus CS cTnI Acute Care Testpak.
-
- Terminated Z-2135-2019
Potential for increased rate of false positive results and/or increased rate of random non-repeatable false positive results.
-
- Terminated Z-0612-2016
- Terminated Z-0609-2016
- Terminated Z-0618-2016
- Terminated Z-0613-2016
- Terminated Z-0619-2016
Stratus CS Cartridge Barcode labels may not scan on the Stratus CS systems
-
- Terminated Z-1732-2011
Low frequency of non-repeatable falsely elevated CTNI results without an associated error message.
-
- Terminated Z-2400-2010
False elevated Stratus CS CTNI results
-
- Terminated Z-0668-2009
Incorrect result: Potential for false elevation of CTnI results
-
- Terminated Z-1555-2009
The firm received and confirmed that some lots of Cardiac Troponin I (cTnl) CalPaks (CCTNI-CR) may exhibit calibration issues that cause lower than typical signal during calibration with the current population of cTnl TestPaks (CCTNI). This issue may result in failed calibrations due to "Slope Error" messages or falsely elevated patient sample and quality control (QC) results on calibrations that
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JHX
- Models / Variants
- Stratus Cs Acute Care Ckmb Testpak.
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1215
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent